2009
Clock-Cancer Connection in Non–Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2
Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, Yi C, Holford TR, Zhu Y. Clock-Cancer Connection in Non–Hodgkin's Lymphoma: A Genetic Association Study and Pathway Analysis of the Circadian Gene Cryptochrome 2. Cancer Research 2009, 69: 3605-3613. PMID: 19318546, PMCID: PMC3175639, DOI: 10.1158/0008-5472.can-08-4572.Peer-Reviewed Original ResearchConceptsCryptochrome 2Single nucleotide polymorphismsCircadian genesWhole-genome expression microarraysPathway-based analysisCore circadian genesCancer-related biological pathwaysCRY2 knockdownTranscriptional repressorGenetic association analysisGenetic association studiesExpression microarraysFunctional analysisPathway analysisAssociation studiesBiological pathwaysAssociation analysisGenesNucleotide polymorphismsGenetic associationCircadian biomarkersDNA samplesFunctional effectsImportant roleRepressor
2004
Re: No Increased Risk of non-Hodgkin's Lymphoma with Steroids, Estrogens and Psychotropics (Netherlands)
Zheng T, Zhang Y, Morton L, Zhu Y. Re: No Increased Risk of non-Hodgkin's Lymphoma with Steroids, Estrogens and Psychotropics (Netherlands). Cancer Causes & Control 2004, 15: 433-434. PMID: 15248307, DOI: 10.1023/b:caco.0000027551.90202.5a.Commentaries, Editorials and LettersAdrenal Cortex HormonesEstrogensHumansLymphoma, Non-HodgkinNetherlandsPsychotropic DrugsRisk Factors